MIST

Healthcare Biotechnology

Milestone Pharmaceuticals Inc.

$0.81

-0.01 -1.23% today

Price History

Not enough data

Key Stats

Market Cap

100.84M

Avg Volume

1.42M

EPS

-$0.65

52W High

$3.06

52W Low

$0.75

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-1.05

P/B Ratio

6.28

P/S Ratio

43.02

EV/EBITDA

-1.09

EV/Revenue

36.41

Margins

Gross Margin 98.0%

Operating Margin (4585.0%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(35522.6%)

Return on Assets

(42.8%)

Liquidity & Leverage

Current Ratio

8.13

Quick Ratio

7.87

Debt / Equity

7.79

Total Cash

170.61M

Total Debt

141.83M

About

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.